News
Urticaria is complicated to diagnose by its symptomatic overlap with other skin conditions and the frequent misclassification ...
Top solutions for prickly heat revealed - Discover the most effective treatments for sweat rash and how they can help ...
For those with surface skin cancer, new technology offers a non-surgical treatment option. Dr. Muennich is among the few in ...
12h
Reader's Digest Canada on MSN30 Old-Time Home Remedies That Actually WorkTime Home Remedies That Actually Work appeared first on Reader's Digest Canada.
May is Lyme Disease Awareness Month and the charity, Lyme Disease UK, is urging the public to look out for these dangerous arachnids which may ...
The FDA has approved Dupixent for the treatment of patients aged 12 years and older with CSU who remain symptomatic despite H1 antihistamine treatment.
Lipella Pharmaceuticals Inc. (Nasdaq: LIPO) (“Lipella,” “our,” “us,” or the “Company”), a clinical-stage biotechnology company addressing serious diseases with significant unmet needs, today announced ...
The FDA has approved the popular drug Dupixent (generic name, dupilumab) for adults and kids 12 and up with chronic spontaneous urticaria (CSU), a long-lasting itchy skin condition, when regular ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results